• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

作者信息

Maier Lisa A, Barkes Briana Q, Mroz Margaret, Rossman Milton D, Barnard Juliana, Gillespie May, Martin Allison, Mack Douglas G, Silveira Lori, Sawyer Richard T, Newman Lee S, Fontenot Andrew P

出版信息

Respir Med. 2012 Dec;106(12):1810-3. doi: 10.1016/j.rmed.2012.08.014. Epub 2012 Sep 11.

DOI:10.1016/j.rmed.2012.08.014
PMID:22974830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4347848/
Abstract
摘要

相似文献

1
Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.英夫利昔单抗治疗可调节慢性铍病中的抗原特异性免疫反应。
Respir Med. 2012 Dec;106(12):1810-3. doi: 10.1016/j.rmed.2012.08.014. Epub 2012 Sep 11.
2
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.5-氨基水杨酸调节慢性铍病患者的免疫反应。
Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27.
3
Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.激活途径表明，抗HLA-DP和抗LFA-1抗体是干预慢性铍病的主要候选药物。
J Immunol. 2005 Apr 1;174(7):4316-24. doi: 10.4049/jimmunol.174.7.4316.
4
Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-α chimeric monoclonal antibody infliximab in complex regional pain syndrome.复杂区域疼痛综合征中抗 TNF-α嵌合单克隆抗体英夫利昔单抗的初步停药双盲、随机、安慰剂对照试验报告。
Pain Pract. 2013 Nov;13(8):633-40. doi: 10.1111/papr.12078. Epub 2013 May 22.
5
[Correlation of the humoral and cellular immunological response in berylliosis].[铍中毒中体液免疫和细胞免疫反应的相关性]
Gig Tr Prof Zabol. 1980 Aug(8):50-1.
6
Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease.抗氧化剂对慢性铍病中淋巴细胞增殖的调节作用
Am J Respir Crit Care Med. 2008 May 1;177(9):1002-11. doi: 10.1164/rccm.200707-1021OC. Epub 2008 Jan 24.
7
Commentary on "pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD".关于“pANCA阳性预示炎症性肠病患者对英夫利昔单抗治疗的临床反应较低”的评论
South Med J. 2015 Mar;108(3):144. doi: 10.14423/SMJ.0000000000000252.
8
Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.克罗恩病与化脓性汗腺炎。一种对英夫利昔单抗有反应的罕见关联。
J Crohns Colitis. 2013 Dec;7(12):e717-8. doi: 10.1016/j.crohns.2013.08.016. Epub 2013 Sep 29.
9
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.英夫利昔单抗强化川崎病一线治疗：一项 3 期随机、双盲、安慰剂对照试验。
Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24.
10
Concurrent Sjögren's syndrome in a patient with ulcerative colitis during infliximab therapy: a rare association.英夫利昔单抗治疗期间溃疡性结肠炎患者并发干燥综合征：一种罕见的关联。
J Crohns Colitis. 2013 Sep;7(8):e327-8. doi: 10.1016/j.crohns.2013.01.008. Epub 2013 Feb 4.

引用本文的文献

1
Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.非感染性肉芽肿性肺病中的固有免疫和适应性免疫。
J Immunol. 2022 Apr 15;208(8):1835-1843. doi: 10.4049/jimmunol.2101159.
2
Pulmonary granulomatosis of genetic origin.遗传性肺肉芽肿病。
Eur Respir Rev. 2021 Apr 29;30(160). doi: 10.1183/16000617.0152-2020. Print 2021 Jun 30.
3
Pulmonary Macrophage Cell Death in Lung Health and Disease.肺部健康与疾病中的肺巨噬细胞死亡
Am J Respir Cell Mol Biol. 2021 May;64(5):547-556. doi: 10.1165/rcmb.2020-0420TR.
4
A role for TNF-α in alveolar macrophage damage-associated molecular pattern release.TNF-α 在肺泡巨噬细胞损伤相关分子模式释放中的作用。
JCI Insight. 2020 May 7;5(9):134356. doi: 10.1172/jci.insight.134356.
5
Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?临床诊断为矽肺的患者出现结节病；二氧化硅相关性结节病是一种新的表型吗？
Respir Med Case Rep. 2019 Jul 10;28:100906. doi: 10.1016/j.rmcr.2019.100906. eCollection 2019.
6
Effect of inhaled corticosteroids on lung function in chronic beryllium disease.吸入性糖皮质激素对慢性铍病肺功能的影响。
Respir Med. 2018 May;138S:S14-S19. doi: 10.1016/j.rmed.2018.01.009. Epub 2018 Feb 5.
7
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.5-氨基水杨酸调节慢性铍病患者的免疫反应。
Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27.
8
Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.铍诱导的肺部疾病表现出与结节病相似的表达谱。
Eur Respir J. 2016 Jun;47(6):1797-808. doi: 10.1183/13993003.01469-2015. Epub 2016 Apr 21.
9
Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2.慢性铍病：揭示铍离子和小肽与HLA - DP2结合的作用
PLoS One. 2014 Nov 4;9(11):e111604. doi: 10.1371/journal.pone.0111604. eCollection 2014.

本文引用的文献

1
Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.慢性铍病患者肺部调节 T 细胞缺失和功能障碍。
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1241-9. doi: 10.1164/rccm.201001-0025OC. Epub 2010 Mar 18.
2
Long-term follow-up of beryllium sensitized workers from a single employer.单一雇主的铍致敏工人的长期随访。
BMC Public Health. 2010 Jan 4;10:5. doi: 10.1186/1471-2458-10-5.
3
Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.铍淋巴细胞增殖试验监测可识别临床上有意义的铍病。
Am J Ind Med. 2009 Oct;52(10):762-73. doi: 10.1002/ajim.20736.
4
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review.随机试验中SF-36结果的报告与解读：系统评价
BMJ. 2009 Jan 12;338:a3006. doi: 10.1136/bmj.a3006.
5
Short- and long-term response to corticosteroid therapy in chronic beryllium disease.慢性铍病患者对皮质类固醇疗法的短期和长期反应
Eur Respir J. 2008 Sep;32(3):687-93. doi: 10.1183/09031936.00149607.
6
Immunology of chronic beryllium disease.慢性铍病的免疫学
Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):126-34. doi: 10.1097/ACI.0b013e3282f824a4.
7
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.英夫利昔单抗治疗对炎性风湿性疾病患者生活质量的影响。
Arthritis Res Ther. 2007;9(5):R103. doi: 10.1186/ar2306.
8
Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.抗TNF-α疗法通过转化生长因子-β在类风湿关节炎患者中诱导出独特的调节性T细胞群体。
J Exp Med. 2007 Jan 22;204(1):33-9. doi: 10.1084/jem.20061531. Epub 2007 Jan 2.
9
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.英夫利昔单抗治疗慢性结节病合并肺部受累患者。
Am J Respir Crit Care Med. 2006 Oct 1;174(7):795-802. doi: 10.1164/rccm.200603-402OC. Epub 2006 Jul 13.
10
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.英夫利昔单抗可改善银屑病关节炎患者的健康相关生活质量和身体功能。
Ann Rheum Dis. 2006 Apr;65(4):471-7. doi: 10.1136/ard.2005.040196. Epub 2005 Aug 11.